Company overview
Opentrons builds accessible, modular lab automation platforms that help life sciences organizations streamline sample prep, improve reproducibility, and accelerate R&D. Its flagship products—the compact OT-2 pipetting robot and the more powerful Flex system—combine precise, programmable hardware with intuitive software tools for protocol design and execution. The OT-2 supports a wide range of workflows through interchangeable pipettes and plug-and-play modules, while the Flex adds high-throughput capabilities like 96-channel pipetting and robotic grippers. Both systems run on Opentrons' open-source Python API and no-code Protocol Designer, and can integrate with validated protocols and third-party tools via the Opentrons Automation Marketplace.
Opentrons operates under a hybrid recurring sales model. Customers purchase hardware outright—starting around $6,500 for an OT-2 or $26,000+ for a Flex—and can expand functionality with modules and consumables. Ongoing revenue comes from tip racks, labware, software support plans, and optional onboarding and integration services. This structure enables labs to start with a single robot and scale up over time, with flexible options for automation support without committing to proprietary ecosystems or costly long-term contracts.
Customers and target markets
- Carnegie Mellon University
- DAMP lab
- UTMB Health
Company metrics
- Headquarters:
- Long Island City, New York
- Company size:
- 51-200
- Founded:
- 2014
- Industries:
